Criteo
CRTO
15.02
+0.12
+0.81%
Criteo
US · CRTO
#3480 by market cap
15.02
+0.12
+0.81%
Live - 5344 symbols - heartbeat 484s ago
· 2026-10-08 10:05
Pre-market
14.86
-0.25%
After-hours
14.90
0.00%
- Market cap
- 735.94M
- P/E (TTM)i
- 7.66
- P/Bi
- 0.65
- EPSi
- 2.64
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on CRTO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.15, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.60% YoY
Margins
- Gross margin
- 53.96%
- Operating margin
- 10.43%
- Net margin
- 7.43%
Key ratios & quality
- PEG ratioi
- 0.05
- Altman Z-Scorei
- 2.15
PEG uses trailing P/E against the 3-year net income growth rate (152.79%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.30B | 2.26B | 2.07B | 2.25B | 2.02B | 1.95B | 1.93B | 1.94B |
| Gross profit | 834.24M | 829.04M | 688.02M | 781.94M | 795.20M | 863.04M | 982.97M | 1.05B |
| Selling & admin expenses | 497.87M | 503.35M | 446.68M | 478.25M | 583.33M | 543.54M | 552.23M | 563.31M |
| Research & development | 179.26M | 172.59M | 132.51M | 151.82M | 187.60M | 242.29M | 279.34M | 283.30M |
| Operating profit | 147.11M | 141.21M | 108.83M | 151.88M | 24.28M | 77.22M | 151.40M | 202.77M |
| Pretax profit | 142.02M | 135.47M | 106.89M | 153.82M | 42.06M | 74.73M | 154.50M | 203.57M |
| Tax | 46.14M | 39.50M | 32.20M | 16.17M | 31.19M | 20.08M | 39.78M | 54.20M |
| Net profit | 95.88M | 95.97M | 74.69M | 137.65M | 10.88M | 54.64M | 114.71M | 149.38M |
| Basic EPS | 1 | 1 | 1 | 2 | 0 | 1 | 2 | 3 |
| Diluted EPS | 1.31 | 1.38 | 1.16 | 2.09 | 0.14 | 0.88 | 1.90 | 2.64 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 451.43M | 482.67M | 469.66M | 541.14M | 424.64M | 428.02M |
| Gross profit | 236.98M | 258.52M | 256.48M | 297.40M | 222.74M | 222.21M |
| Selling & admin expenses | 128.06M | 148.45M | 137.18M | 149.62M | 142.66M | 135.26M |
| Research & development | 60.75M | 79.61M | 67.68M | 75.27M | 69.68M | 71.95M |
| Operating profit | 48.17M | 30.46M | 51.63M | 72.51M | 10.40M | 15.01M |
| Pretax profit | 50.47M | 28.65M | 51.61M | 72.84M | 12.27M | 15.33M |
| Tax | 10.46M | 5.73M | 11.53M | 26.47M | 3.69M | 3.58M |
| Net profit | 40.01M | 22.92M | 40.08M | 46.37M | 8.58M | 11.75M |
| Basic EPS | 1 | 0 | 1 | 1 | 0 | 0 |
| Diluted EPS | 0.66 | 0.39 | 0.70 | 0.90 | 0.15 | 0.22 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 933.85M | 1.00B | 1.06B | 1.26B | 1.26B | 1.31B | 1.22B | 1.07B |
| Cash & ST investments | 364.43M | 418.76M | 488.01M | 565.83M | 373.30M | 342.31M | 316.94M | 365.28M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.60B | 1.79B | 1.85B | 1.98B | 2.35B | 2.39B | 2.27B | 2.20B |
| Total current liabilities | 605.34M | 610.34M | 600.33M | 672.55M | 1.08B | 1.14B | 1.05B | 844.65M |
| Short-term debt | -- | 45.85M | 48.39M | 34.07M | 31.00M | 35.40M | 25.81M | 33.09M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 629,244,000.00 | 752,396,000.00 | 700,723,000.00 | 785,271,000.00 | 1,267,788,000.00 | 1,280,158,000.00 | 1,185,352,000.00 | 1,015,478,000.00 |
| Total equity | 967.89M | 1.04B | 1.15B | 1.20B | 1.08B | 1.11B | 1.08B | 1.19B |
| Retained earnings | 387.87M | 451.73M | 491.36M | 601.59M | 577.65M | 555.46M | 571.74M | 630.75M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.08B | 1.03B | 1.01B | 1.07B | 940.29M | 873.07M |
| Cash & ST investments | 313.15M | 223.59M | 278.76M | 365.28M | 348.33M | 280.29M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.13B | 2.11B | 2.06B | 2.20B | 2.07B | 2.01B |
| Total current liabilities | 886.80M | 833.55M | 755.11M | 844.65M | 737.05M | 677.72M |
| Short-term debt | 25.63M | 29.05M | 27.13M | 33.09M | 34.48M | 36.41M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,027,709,000.00 | 986,611,000.00 | 891,349,000.00 | 1,015,478,000.00 | 902,615,000.00 | 846,653,000.00 |
| Total equity | 1.10B | 1.13B | 1.17B | 1.19B | 1.17B | 1.16B |
| Retained earnings | 607.42M | 627.08M | 661.50M | 630.75M | 635.94M | 608.28M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 260.73M | 222.83M | 185.36M | 220.91M | 255.99M | 224.25M | 258.16M | 311.24M |
| Depreciation & amortization | 111.83M | 97.11M | 106.59M | 90.93M | 150.26M | 72.34M | 87.75M | 129.45M |
| Free cash flow | 143.74M | 124.89M | 118.07M | 165.93M | 192.17M | 108.13M | 180.05M | 208.50M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -78.53M | -56.90M | -41.93M | -74.83M | -134.66M | -123.54M | -220.05M | -150.17M |
| Ending cash balance | 364.43M | 418.76M | 488.01M | 515.53M | 448.20M | 411.34M | 290.94M | 342.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 62.34M | -1.40M | 89.60M | 160.69M | 48.21M | 20.30M |
| Depreciation & amortization | 23.58M | 36.90M | 36.63M | 32.33M | 28.57M | 23.47M |
| Free cash flow | 45.25M | -36.65M | 66.63M | 133.26M | 15.36M | -37.94M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -56.17M | -48.33M | -10.95M | -34.72M | -30.97M | -30.35M |
| Ending cash balance | 286.17M | 206.02M | 255.34M | 342.36M | 320.30M | 252.34M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.71 | 9.30 | 6.75 | 11.79 | 0.81 | 5.01 | 10.48 | 13.16 |
| ROA %i | 5.67 | 5.36 | 3.93 | 7.01 | 0.41 | 2.23 | 4.75 | 6.47 |
| ROIC %i | 9.77 | 7.98 | 6.00 | 10.68 | 1.01 | 4.70 | 9.08 | 11.66 |
| 5-year avg ROE %i | 12.48 | 12.01 | 10.68 | 9.97 | 7.67 | 6.73 | 6.97 | 8.25 |
| EBIT margin %i | 6.25 | 6.07 | 5.27 | 6.91 | 2.39 | 4.22 | 8.18 | 10.59 |
| FCF / sales %i | 6.25 | 6.20 | 5.70 | 7.36 | 8.49 | 6.76 | 9.31 | 10.72 |
| Current ratioi | 1.54 | 1.64 | 1.77 | 1.88 | 1.17 | 1.15 | 1.17 | 1.27 |
| Quick ratioi | 1.51 | 1.62 | 1.75 | 1.84 | 1.10 | 1.04 | 1.12 | 1.21 |
| Debt / assetsi | 0.00 | 9.15 | 7.09 | 6.45 | 4.62 | 4.95 | 4.56 | 6.29 |
| LT debt / equityi | -- | 11.71 | 7.43 | 8.07 | 7.40 | 7.69 | 7.39 | 9.16 |
| Interest coveragei | 80.08 | 78.14 | 45.89 | 78.37 | 7.76 | 10.92 | 44.02 | 83.72 |
| Revenue CAGR (3Y) %i | 20.24 | 7.92 | -3.36 | -0.67 | -3.74 | -2.02 | -4.99 | -1.21 |
| Net income CAGR (3Y) %i | 14.18 | 3.32 | -7.72 | 14.90 | -53.79 | -9.43 | -6.03 | 152.79 |
| FCF CAGR (3Y) %i | 32.68 | 22.26 | -1.42 | 4.90 | 15.45 | -2.89 | 2.76 | 2.76 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.51 | 12.81 | 15.40 | 13.16 | 10.42 | 9.42 |
| ROA %i | 6.56 | 6.38 | 7.87 | 6.47 | 5.45 | 5.06 |
| ROIC %i | 11.75 | 11.14 | 13.55 | 11.66 | 9.18 | 8.16 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.09 | 9.64 | 11.74 | 10.59 | 8.77 | 8.31 |
| FCF / sales %i | 11.64 | 9.89 | 11.27 | 10.72 | 9.31 | 9.52 |
| Current ratioi | 1.22 | 1.23 | 1.33 | 1.27 | 1.28 | 1.29 |
| Quick ratioi | 1.15 | 1.17 | 1.26 | 1.21 | 1.18 | 1.20 |
| Debt / assetsi | 4.86 | 5.56 | 5.30 | 6.29 | 6.45 | 6.89 |
| LT debt / equityi | 7.31 | 8.12 | 7.27 | 9.16 | 8.76 | 9.06 |
| Interest coveragei | 107.28 | 90.11 | 100.67 | 83.72 | 60.17 | 55.36 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Performance Media is the largest reported line at 88.81% of revenue, across 2 reported segments.
- The next-largest line, Retail Media, is a distant second at 11.19% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Performance Media88.81%
Retail Media11.19%
Quote time 2026-10-08 10:05:51 · For reference only, not investment advice and not tailored to your situation.